Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Major Depressive Disorder according to DSM-IV criteria with at least one previous depressive episode in the patient's medical history~* Painful physical symptoms as measured by the Brief Pain Inventory-Short Form~Exclusion Criteria:~* Any anxiety disorder as a primary diagnosis within the past 6 months (including panic disorder, OCD, PTSD, generalized anxiety disorder and social phobia)~* Any diagnosis of bipolar disorder, schizophrenia, or other psychotic disorders

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).